Please use this identifier to cite or link to this item: http://repository.i3l.ac.id/jspui/handle/123456789/539
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRenantha, Rachel Raditya-
dc.date.accessioned2022-09-20T04:02:29Z-
dc.date.available2022-09-20T04:02:29Z-
dc.date.issued2022-06-03-
dc.identifier.urihttp://repository.i3l.ac.id/jspui/handle/123456789/539-
dc.description.abstractIn 2020, breast cancer incidence in Indonesian women had become the highest among other cancers. There are different approaches to combat this disease; one of them is immunotherapy which focuses on utilizing the body’s immune cells to eliminate and evoke an immune response against cancer. This study aims to develop a multi-epitope peptide-based vaccine targeting Mucin 1 (MUC-1) and Matrix Metalloproteinase 9 (MMP-9), which are overexpressed in breast cancer, for the Indonesian population using immunoinformatics tools. The NetCTLpan and NetMHCIIpan were utilized to find the cytotoxic T cell and helper T cell epitopes, respectively. The B cell epitopes were predicted using Linear Bepipred 1.0, Emini’s surface accessibility, and Kolaskar and Tongaonkar antigenicity methods available in IEDB. The selected epitopes fulfilling criteria such as immunogenic, able to induce IFNγ, and promiscuous for the T cells and predicted in three methods for B cells were assembled using Heparin-Binding Hemagglutinin Adhesin (HBHA) as the adjuvant and linkers. Other evaluations of vaccine construct to determine its efficacy and safety were also performed. The final vaccine design was antigenic, non-allergenic, stable, not likely to induce autoimmunity and disrupt the gut microbiomes homeostasis, able to cover the vast majority of the Indonesian population, and able to induce immune responses. The docking simulations showed that the vaccine construct could bind with TLR4, and 1040SFFFLSFHI1049 peptide was able to bind with both HLA-A*24:07 and HLA-A*24:02. Even though the vaccine construct seems promising, further studies are needed to confirm the results of this study.en_US
dc.language.isoenen_US
dc.publisherIndonesia International Institute for Life Sciencesen_US
dc.relation.ispartofseriesBM 22-004;T202206006-
dc.subjectvaccineen_US
dc.subjectimmunoinformaticsen_US
dc.subjectbreast canceren_US
dc.subjectMucin-1 (MUC-1)en_US
dc.subjectMatrix Metalloproteinase-9 (MMP-9)en_US
dc.titleImmunoinformatics Analysis to Design a Multiepitope Peptide-Based Breast Cancer Vaccine by Targeting Mucin-1 (MUC-1) and Matrix Metalloproteinase-9 (MMP-9) for Indonesian Populationen_US
dc.typeThesisen_US
Appears in Collections:Biomedicine

Files in This Item:
File Description SizeFormat 
BM 22-004 Rachel Raditya Renatha.pdf
  Restricted Access
Full Text8.18 MBAdobe PDFView/Open Request a copy
Cover.pdfCover416.45 kBAdobe PDFView/Open
abstract.pdfAbstract590.11 kBAdobe PDFView/Open
Chapter 1.pdfChapter 1607.97 kBAdobe PDFView/Open
References.pdfReferences843.8 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.